Simplex Trading, LLC Vbi Vaccines Inc Transaction History

Simplex Trading, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.29 - $0.64 $18,382 - $40,568	-63,389 Reduced 98.66%	864 $0
Q4 2022 Feb 02, 2023	SELL	$0.38 - $22.5 $877 - $51,975	-2,310 Reduced 3.47%	64,253 $25,000
Q3 2022 Nov 04, 2022	BUY	$0.73 - $23.4 $17,445 - $559,213	23,898 Added 56.01%	66,563 $46,000
Q2 2022 Aug 03, 2022	BUY	$0.66 - $1.81 $17,334 - $47,539	26,265 Added 160.15%	42,665 $34,000
Q1 2022 May 02, 2022	SELL	$1.27 - $2.47 $22,903 - $44,543	-18,034 Reduced 52.37%	16,400 $27,000
Q4 2021 Feb 23, 2022	BUY	$2.21 - $3.22 $13,434 - $19,574	6,079 Added 21.44%	34,434 $80,000
Q2 2021 Aug 12, 2021	BUY	$2.61 - $4.17 $2,727 - $4,357	1,045 Added 3.83%	28,355 $94,000
Q1 2021 Apr 26, 2021	SELL	$2.91 - $4.32 $75,697 - $112,376	-26,013 Reduced 48.78%	27,310 $84,000
Q4 2020 Feb 02, 2021	SELL	$2.15 - $3.5 $44,799 - $72,929	-20,837 Reduced 28.1%	53,323 $146,000
Q3 2020 Oct 14, 2020	BUY	$2.77 - $6.17 $205,146 - $456,950	74,060 Added 74060.0%	74,160 $212,000
Q2 2020 Jul 13, 2020	BUY	$0.87 - $3.13 $87 - $313	100 New	100 $0
Q1 2020 Apr 29, 2020	SELL	$0.73 - $1.91 $190 - $498	-261 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$0.48 - $1.38 $125 - $360	261 New	261 $0
Q2 2019 Jul 26, 2019	SELL	$0.65 - $2.12 $49 - $161	-76 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$1.54 - $2.01 $117 - $152	76 New	76 $0
Q4 2018 Jan 16, 2019	SELL	$1.22 - $2.41 $1,265 - $2,499	-1,037 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$1.75 - $2.93 $854 - $1,429	488 Added 88.89%	1,037 $2,000
Q2 2018 Jul 30, 2018	BUY	$2.75 - $3.85 $1,509 - $2,113	549 New	549 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.